Name | Value |
---|---|
Revenues | 0.0K |
Cost of Revenue | 342.8K |
Gross Profit | -342.8K |
Operating Expense | 342.8K |
Operating I/L | -342.8K |
Other Income/Expense | 156.8K |
Interest Income | 156.8K |
Pretax | -186.0K |
Income Tax Expense | 2.9K |
Net Income/Loss | -188.9K |
Monterey Bio Acquisition Corporation is a blank check company that focuses on identifying and merging with businesses in the biotech industry. It does not have significant operations of its own but seeks to facilitate mergers, capital stock exchanges, asset acquisitions, stock purchases, or reorganizations with biotech companies. The company, formerly known as Chardan FinTech Acquisition Corp., aims to generate revenue through these business combinations and related transactions within the biotech sector.